Sales rise 38.46% to Rs 0.36 crore
Net profit of Rubra Medicaments remain constant at Rs 0.01 crore in the quarter ended September 2022 and also during the previous quarter ended September 2021. Sales rose 38.46% to Rs 0.36 crore in the quarter ended September 2022 as against Rs 0.26 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales0.360.26 38 OPM %2.787.69 -PBDT0.010.02 -50 PBT0.010.02 -50 NP0.010.01 0Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
